JP Patent

JP2651616B2 — 経皮吸収製剤

Assigned to RINTETSUKU KK · Expires 1997-09-10 · 29y expired

What this patent protects

Patent listed against Estrace.

Drugs covered by this patent

Estrace (ESTRADIOL) · Pfizer

Patent Metadata

Patent number: JP2651616B2
Jurisdiction: JP
Classification: —
Expires: 1997-09-10
Drug substance claim: No
Drug product claim: No
Assignee: RINTETSUKU KK
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.